I would say you are correct except that the dosing for efficacy on mild AD is yet to be discovered or demonstrated, so IMO it would be too risky to go straight to a large trial.
@US10 silence since XanaHES announcement, page-36
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.28M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.7¢ | $5.413K | 193.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 147840 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.9¢ | 2.9¢ | 2.8¢ | 114897 | ||
| Last updated 11.41am 03/06/2024 ? | |||||
| ACW (ASX) Chart |